Pliant Therapeutics Inc logo

Pliant Therapeutics Inc

$ 19.21 -0.68 (-3.42%) 04:00 PM EST
P/E:
At Loss
P/B:
4.94
Market Cap:
$ 928.13M
Enterprise V:
$ 808.45M
Volume:
171.32K
Avg Vol (2M):
2.99M
Also Trade In:
Volume:
171.32K
Market Cap $:
928.13M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.99M
Enterprise Value $:
808.45M
PB Ratio:
4.94
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Pliant Therapeutics Inc
NAICS : 541714 SIC : 2833
260 Littlefield Avenue, South San Francisco, CA, USA, 94080
Description
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
Name Current Vs Industry Vs History
Cash-To-Debt 10.02
Equity-to-Asset 0.8
Debt-to-Equity 0.11
Debt-to-EBITDA -0.15
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 12.68
Distress
Grey
Safe
Beneish M-Score -1.58
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -13.5
3-Year EPS without NRI Growth Rate -8.4
3-Year FCF Growth Rate -5.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 46.61
9-Day RSI 54.38
14-Day RSI 58.27
6-1 Month Momentum % 99.39
12-1 Month Momentum % 4.24

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.69
Quick Ratio 7.69
Cash Ratio 7.25
Days Sales Outstanding 86.56

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -29.8

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -1112.67
Net Margin % -1109.19
ROE % -55.44
ROA % -49.98
ROIC % -788.76
ROC (Joel Greenblatt) % -1335.74
ROCE % -54.18

Financials (Next Earnings Date:2022-11-09 Est.)

PLRX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:PLRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 9.847
EPS (TTM) ($) -3.03
Beta 0
Volatility % 136.62
14-Day RSI 58.27
14-Day ATR ($) 1.46857
20-Day SMA ($) 18.9185
12-1 Month Momentum % 4.24
52-Week Range ($) 3.965 - 24.17
Shares Outstanding (Mil) 48.68

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pliant Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More